These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8646807)

  • 1. A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer.
    Nardi M; Della Giulia M; Pollera CF; Marolla P; Ruggeri EM; Iacovelli A; Atlante G; Calabresi F
    Cancer Chemother Pharmacol; 1996; 38(3):298-301. PubMed ID: 8646807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy.
    Sørensen P; Pfeiffer P; Bertelsen K
    Gynecol Oncol; 1995 Jan; 56(1):75-8. PubMed ID: 7821851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide and mitoxantrone as first-line chemotherapy for metastatic breast cancer.
    Perez JE; Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Lacava JA; Rodriguez R; Cuevas MA
    J Clin Oncol; 1993 Mar; 11(3):461-6. PubMed ID: 8445421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
    Rodriguez MA; Cabanillas FC; Hagemeister FB; McLaughlin P; Romaguera JE; Swan F; Velasquez W
    Ann Oncol; 1995 Jul; 6(6):609-11. PubMed ID: 8573542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study.
    Baur M; Fazeny-Doerner B; Hudec M; Sevelda P; Salzer H; Dittrich C
    Cancer Invest; 2006 Feb; 24(1):22-7. PubMed ID: 16466988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.
    Miglietta L; Amoroso D; Bruzzone M; Granetto C; Catsafados E; Mammoliti S; Guarneri D; Pedulla F; Foglia G; Ragni N; Martini MC; Brema F; Addamo G; Moraglio L; Pastorino G; Boccardo F
    Oncology; 1997; 54(2):102-7. PubMed ID: 9075779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Thurnher D; Kornfehl J; Burian M; Gedlicka C; Selzer E; Quint C; Neuchrist C; Kornek GV
    Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Homesley HD; McGuire WP; Adcock L
    Cancer; 1994 Mar; 73(5):1453-5. PubMed ID: 8111713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
    Polyzos A; Kosmas C; Tsavaris N; Toufexi H; Lagadas A; Gogas H; Giannakopoulos K; Kouraklis G; Griniatsos J; Felekouras E; Tsigris C; Nikiteas N; Papadopoulos O; Giannopoulos A
    Anticancer Res; 2007; 27(3B):1645-51. PubMed ID: 17595790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Lund B; Hansen OP; Hansen HH; Hansen M
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma.
    Leone B; Vallejo C; Perez J; Cuevas MA; Machiavelli M; Lacava J; Focaccia G; Ferreyra R; Suttora G; Romero A; Castaldi J; Arroyo A; Rabinovich M
    Am J Clin Oncol; 1996 Apr; 19(2):132-5. PubMed ID: 8610635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage therapy with ifosfamide and mitoxantrone in advanced ovarian cancer.
    Marzola M; Parma G; Bonazzi C; Colombo N; Maneo A; Pittelli MR; Mangioni C
    Ann Oncol; 1996 Apr; 7(4):419-21. PubMed ID: 8805937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.
    Kiraz S; Baltali E; Güler N; Barista I; Benekli M; Celik I; Güllü IH; Kars A; Tekuzman G; Firat D
    J Chemother; 1996 Aug; 8(4):310-4. PubMed ID: 8873839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer.
    Araujo CE; Cervellino JC; Pirisi C; Pannunzio O; Callegari J
    J Surg Oncol; 1991 Mar; 46(3):198-202. PubMed ID: 1901372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer].
    Chu P; Lu CH; Sheng XG; Zhou CX; Li DP; DU XL; Liu NF
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):808-12. PubMed ID: 21211276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cis-platinum and ifosfamide in alkylating agent-resistant ovarian cancer.
    Green JA; Slater AJ
    Gynecol Oncol; 1989 Feb; 32(2):233-5. PubMed ID: 2910785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
    Willemse PH; vd Burg ME; vd Gaast A; Neijt JP; ten Bokkel Huinink WW; Aalders JG; de Vries EG
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S51-4. PubMed ID: 2112053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma.
    Baker TR; Piver MS; Hempling RE
    Eur J Gynaecol Oncol; 1993; 14(1):18-22. PubMed ID: 8472726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.
    Papadimitriou CA; Kouroussis C; Moulopoulos LA; Vlahos G; Rodolakis A; Kiamouris C; Diakomanolis E; Gika D; Michalas S; Dimopoulos MA
    Cancer; 2001 Oct; 92(7):1856-63. PubMed ID: 11745258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
    Mayer J; Vásová I; Korístek Z; Navrátil M; Klabusay M; Doubek M; Vorlícek J; Cernilová I; Vodvárka P; Petráková K
    Eur J Haematol Suppl; 2001 Jul; 64():21-7. PubMed ID: 11486396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.